|
⚲
|
| Keyboard |
| Immix Biopharma Inc | |
|---|---|
| Ticker | IMMX |
| CIK # | 0001873835 |
| CUSIP | 45258H106 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 11400 West Olympic Blvd Suite 200, Los Angeles, CA 90064 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Immix Biopharma Inc | 2024-05-20 | Exemption: 506(b) · Remaining: Indefinite · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001873835] | 10-K | |
| [0001873835] | 10-Q | |
| [0001873835] | 3 | |
| [0001873835] | 4 | |
| [0001873835] | 8-K | |
| [0001873835] | D | |
| [0001873835] | SC 13D | |
| [0001873835] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Millennium Management LLC | Immix Biopharma Inc | [2026-03-20] | 0.0 |
| Saturn V Capital Management LP | Immix Biopharma Inc | [2026-02-17] | 0.0 |
| Janus Henderson Group PLC | Immix Biopharma Inc | [2026-02-17] | 0.0 |
| Hirschman Orin | Immix Biopharma Inc | [2024-02-07] | 5.8 |
| GKCC LLC | Immix Biopharma Inc | [2023-08-30] | 19.99 |
| Murchinson Ltd | Immix Biopharma Inc | [2022-02-09] | 5.28 |
| Altium Capital Management LP | Immix Biopharma Inc | [2021-12-28] | 8.2 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Morris Gabriel S
Common Stock
|
2025-12-10 | Buy | 770 | $6.58 | 5,067 |
|
Rachman Ilya M
Common Stock
|
2025-12-10 | Buy | 746 | $6.67 | 4,976 |
|
Morris Gabriel S
Warrants (right to purchase) · derivative
|
2025-12-08 | Option exercise | 96,000 | $0.00 | |
|
Morris Gabriel S
Common Stock
|
2025-12-08 | Option exercise | 156,000 | $0.80 | 124,800 |
|
Morris Gabriel S
Warrants (right to purchase) · derivative
|
2025-12-08 | Option exercise | 60,000 | $0.00 | |
|
Chang Nancy T
Stock Option (Right to Buy) · derivative
|
2025-11-21 | Grant | 39,643 | $0.00 | |
|
Common Stock
|
2025-09-17 | Buy | 2,500 | $2.02 | 5,050 |
|
Common Stock
|
2025-09-16 | Buy | 2,600 | $1.97 | 5,122 |
|
Adams Helen C
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 33,000 | $0.00 | |
|
Hsu Jason
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 33,000 | $0.00 | |
|
Marquet Magda
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 33,000 | $0.00 | |
|
Buchan Jane
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 33,000 | $0.00 | |
|
Morris Gabriel S
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 340,000 | $0.00 | |
|
Chudnovsky Yekaterina
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 33,000 | $0.00 | |
|
Rachman Ilya M
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 340,000 | $0.00 | |
|
Ng Carey
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 33,000 | $0.00 | |
|
Morris Gabriel S
Common Stock
|
2025-06-18 | Buy | 2,225 | $2.28 | 5,073 |
|
Rachman Ilya M
Common Stock
|
2025-06-18 | Buy | 2,178 | $2.30 | 5,009 |
|
Hsu Jason
Common Stock
|
2024-12-23 | Buy | 40,000 | $2.19 | 87,600 |
|
Hsu Jason
Common Stock
|
2024-12-20 | Buy | 7,700 | $2.17 | 16,709 |
| showing 20 of 108 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 77 | 27,194,678 |
| 2025-12-31 | 67 | 24,470,912 |
| 2025-09-30 | 31 | 2,765,928 |
| 2025-06-30 | 24 | 2,273,396 |
| 2025-03-31 | 23 | 2,907,202 |
| 2024-12-31 | 25 | 2,866,549 |
| 2024-09-30 | 27 | 4,104,767 |
| 2024-06-30 | 32 | 4,397,528 |
| 2024-03-31 | 36 | 5,181,660 |
| 2023-12-31 | 29 | 798,682 |
| 2023-09-30 | 17 | 405,051 |
| 2023-06-30 | 19 | 656,099 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Everhart Financial Group Inc | [2026-06-30] | SOLE | 0 | 10,000 |
| Aspect Partners LLC | [2026-06-30] | SOLE | 88 | 88 | Prev | Page 1 | Next |